biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Midatech and its viability??

<< Previous

Bullboard Posts

Next >>

Post by narmacon Feb 03, 2023 9:27pm

349 Views

Post# 35266372

Midatech and its viability??

Based on the blurb from the AGM Midatech is really insolvent as the deal has been scuttled,,,so I must ask,,,,,,why was xB3 and Bioasis not given the respect of adding the greater portion of potential!!!..The whole situation smells of stinky fish,,!!

Think about it,,,its is CLEAR,,,,we were the key for the combination to be worth the risk of placing large dollars on the binary company!!!

<< Previous

Bullboard Posts

Next >>

MDA Space stock blasts off on Q3 financial results